The third division corresponds to modulatory SPNs, which express slow-acting neurotransmitters and/or neuropeptides and are distributed throughout the hypothalamus, midbrain and brainstem.
Finally, the search for small molecules with biologic-like effects is ongoing and could in due course deliver potent orally bioavailable immune-modulatory agents. The therapeutic goals in RA are ...